March 20, 2020

Cutting through the haze of vaping: A Town Hall discussion

2020 AOAC INTERNATIONAL Midyear Meeting, March 9-13, 2020

Despite their ever-growing acceptance, relatively little work has been done to characterize the vapor from vape device related to the liquid or the cartridges employed. This discussion, held at the AOAC INTERNATIONAL 2020 Midyear Meeting, provided a forum to discuss the analytical science of testing vape devices with an eye towards AOAC’s potential role in vaping testing.

Part 1 – Introduction  – Palmer Orlandi
AOAC INTERNATIONAL Chief Science Officer

 

Speaker 1 – Christopher Hudalla
CSO, ProVerde Labs

 

Speaker 2 – Robert O’Brien
CSO and CEO, Supra RnD Laboratories

NOTE: Dr. O’Brian has posted his presentation as a Slideshare. You can view it here >

Part 1

Part 2

 

Speaker 3 – Andrew Waye
Controlled Substances and Cannabis Branch, Health Canada

Part 1

Q&A portion removed per Health Canada policy

 

Speaker 4 – Catherine Dasenbrock
Director, Inorganic Branch, Forensic Chemistry Center, U.S. Food and Drug Administration

Part 1

Part 2

 

Q & A and Conclusion

Part 1

Part 2